CG Oncology (CGON) Competitors $36.70 -0.34 (-0.92%) Closing price 04:00 PM EasternExtended Trading$36.68 -0.02 (-0.04%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGON vs. QGEN, BBIO, ROIV, ELAN, MRNA, VRNA, RVMD, RGC, GRFS, and RYTMShould you be buying CG Oncology stock or one of its competitors? The main competitors of CG Oncology include Qiagen (QGEN), BridgeBio Pharma (BBIO), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Moderna (MRNA), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Regencell Bioscience (RGC), Grifols (GRFS), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "pharmaceutical products" industry. CG Oncology vs. Its Competitors Qiagen BridgeBio Pharma Roivant Sciences Elanco Animal Health Moderna Verona Pharma PLC American Depositary Share Revolution Medicines Regencell Bioscience Grifols Rhythm Pharmaceuticals CG Oncology (NASDAQ:CGON) and QIAGEN (NYSE:QGEN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations. Which has stronger earnings & valuation, CGON or QGEN? QIAGEN has higher revenue and earnings than CG Oncology. CG Oncology is trading at a lower price-to-earnings ratio than QIAGEN, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCG Oncology$1.14M2,454.71-$88.04M-$1.77-20.73QIAGEN$1.98B5.12$83.59M$1.6926.98 Which has more risk and volatility, CGON or QGEN? CG Oncology has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, QIAGEN has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Do analysts recommend CGON or QGEN? CG Oncology presently has a consensus price target of $56.00, indicating a potential upside of 52.59%. QIAGEN has a consensus price target of $49.69, indicating a potential upside of 8.95%. Given CG Oncology's stronger consensus rating and higher possible upside, research analysts clearly believe CG Oncology is more favorable than QIAGEN.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CG Oncology 0 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.92QIAGEN 0 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.27 Do insiders and institutionals believe in CGON or QGEN? 26.6% of CG Oncology shares are owned by institutional investors. Comparatively, 70.0% of QIAGEN shares are owned by institutional investors. 9.0% of QIAGEN shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is CGON or QGEN more profitable? QIAGEN has a net margin of 18.30% compared to CG Oncology's net margin of -15,945.17%. QIAGEN's return on equity of 14.77% beat CG Oncology's return on equity.Company Net Margins Return on Equity Return on Assets CG Oncology-15,945.17% -19.37% -18.72% QIAGEN 18.30%14.77%8.87% Does the media favor CGON or QGEN? In the previous week, CG Oncology had 11 more articles in the media than QIAGEN. MarketBeat recorded 18 mentions for CG Oncology and 7 mentions for QIAGEN. QIAGEN's average media sentiment score of 0.91 beat CG Oncology's score of 0.53 indicating that QIAGEN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CG Oncology 8 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive QIAGEN 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryQIAGEN beats CG Oncology on 10 of the 17 factors compared between the two stocks. Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGON vs. The Competition Export to ExcelMetricCG OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.82B$3.17B$5.77B$10.52BDividend YieldN/A2.36%5.53%4.57%P/E Ratio-20.7321.0476.4326.62Price / Sales2,454.71407.35534.76119.62Price / CashN/A46.3537.4661.85Price / Book3.819.7813.616.45Net Income-$88.04M-$52.73M$3.29B$271.57M7 Day Performance2.63%2.40%1.67%2.83%1 Month Performance36.33%4.69%4.05%7.27%1 Year Performance-4.28%16.28%80.70%26.07% CG Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGONCG Oncology2.5415 of 5 stars$36.70-0.9%$56.00+52.6%-5.0%$2.82B$1.14M-20.7361Insider TradeGap UpQGENQiagen4.3617 of 5 stars$45.39+0.2%$49.69+9.5%+4.7%$10.07B$2.04B26.825,765BBIOBridgeBio Pharma4.4974 of 5 stars$51.47+0.5%$63.94+24.2%+92.7%$9.79B$235.81M-12.58400ROIVRoivant Sciences3.4223 of 5 stars$13.95-0.9%$17.67+26.6%+24.8%$9.61B$29.05M-19.93860Trending NewsInsider TradeAnalyst RevisionELANElanco Animal Health2.5844 of 5 stars$18.63+0.5%$17.33-6.9%+35.6%$9.21B$4.48B21.669,000MRNAModerna4.4611 of 5 stars$23.88+1.6%$41.81+75.1%-59.6%$9.15B$3.06B-3.175,800Trending NewsVRNAVerona Pharma PLC American Depositary Share2.0358 of 5 stars$106.37-0.1%$109.00+2.5%+254.3%$8.71B$221.67M-107.4430Positive NewsRVMDRevolution Medicines4.2884 of 5 stars$46.20-0.8%$73.67+59.5%-2.2%$8.70BN/A-10.27250RGCRegencell Bioscience0.1406 of 5 stars$14.35-2.4%N/AN/A$7.27BN/A0.0010Gap UpGRFSGrifols3.9109 of 5 stars$9.63-2.5%$10.30+7.0%+8.4%$6.79B$7.81B8.2323,822RYTMRhythm Pharmaceuticals3.2028 of 5 stars$96.03-0.2%$101.57+5.8%+87.5%$6.39B$156.29M-31.90140Positive News Related Companies and Tools Related Companies Qiagen Competitors BridgeBio Pharma Competitors Roivant Sciences Competitors Elanco Animal Health Competitors Moderna Competitors Verona Pharma PLC American Depositary Share Competitors Revolution Medicines Competitors Regencell Bioscience Competitors Grifols Competitors Rhythm Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGON) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGON Stock Alerts